Softbank CEO and Trump to announce $100 billion investment in U.S. by firm

Softbank CEO and Trump to announce 0 billion investment in U.S. by firm


President-elect Donald Trump and SoftBank CEO Masayoshi Son speak to the media in the lobby of Trump Tower in New York on Dec. 6, 2016.

Eduardo Munoz Alvarez | AFP | Getty Images

Softbank CEO Masayoshi Son will announce a $100 billion investment in the U.S. over the next four years during a Monday visit to President-elect Donald Trump’s residence Mar-a-Lago in Palm Beach, Florida, sources familiar with the matter told CNBC’s Sara Eisen.

The billionaire investor and founder of the Japanese tech-investing firm will also promise in the joint announcement with Trump to create 100,000 jobs focused on artificial intelligence and related infrastructure, the sources said. The money will be deployed before the end of Trump’s term.

The funding could come from various sources controlled by Softbank, including the Vision Fund, capital projects or chipmaker Arm Holdings, where the firm is majority owner. Some of the money will not necessarily be newly raised, but could include some funding already announced such as Softbank’s recent $1.5 billion investment in OpenAI, the tech firm behind chatbot ChatGPT.

Softbank’s Son and Trump made a similar announcement in 2016 after Trump was elected president for the first time, with the Japanese firm agreeing to invest $50 billion in the U.S. with the aim to create 50,000 jobs.

Don’t miss these insights from CNBC PRO



Source

Economist Nouriel Roubini: Trump is likely to escalate the Iran war — risking ‘1970s stagflation’
World

Economist Nouriel Roubini: Trump is likely to escalate the Iran war — risking ‘1970s stagflation’

U.S. President Donald Trump is likely to escalate the war with Iran, risking “1970s stagflation” if it does not go as planned, renowned economist and investor Nouriel Roubini told CNBC. Speaking to CNBC’s Carolin Roth at the Ambrosetti Forum in Cernobbio, Italy on Friday, Roubini — best known for predicting the 2008 Global Financial Crisis […]

Read More
AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed
World

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

AstraZeneca‘s stock jumped nearly 5% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift […]

Read More
The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector
World

The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector

This report is from this week’s The Tech Download newsletter. Like what you see? You can subscribe here. Helium has emerged as a key focus for the tech sector as industry watchers cast their minds to the implications of a prolonged Iran war. A byproduct of natural gas production, helium is crucial to semiconductor manufacturing and […]

Read More